✦ LIBER ✦

Adjunctive treatment of partial seizures with tiagabine: A placebo-controlled trial

✍ Scribed by A. Richens; D.W. Chadwick; J.S. Duncan; M. Dam; L. Gram; M. Mikkelsen; J. Morrow; H. Mengel; V. Shu; J.F. McKelvy; M.W. Pierce

Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 414 KB
Volume: 21
Category: Article
ISSN: 0920-1211
DOI: 10.1016/0920-1211(95)00006-v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised double-blind placebo-contro

A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures

✍ P. Loiseau; A.W.C. Yuen; B. Duché; T. Ménager; M.C. Arné-Bès 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 874 KB

Efficacy and safety of lamotrigine (LTG) as add-on therapy was assessed in a randomised double-blind placebo-controlled trial of this drug in 23 adult patients with refractory partial seizures. Fifteen patients showed an improvement on LTG treatment, with a greater than 50% decrease in total seizure

Clinical trial of adjunctive celecoxib t

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

✍ Shahin Akhondzadeh; Sara Jafari; Firoozeh Raisi; Abbas Ali Nasehi; Aboulfazl Gho 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 3 views

Seizure frequency and CSF parameters in

Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures

✍ Elinor Flen-Menachem; Birgitta Söderfelt; Anders Hamberger; Tomas Hedner; Lennar 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 388 KB

Ursodeoxycholic acid as adjunctive thera

Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: A randomized placebo-controlled treatment trial

✍ Albert J. Czaja; Herschel A. Carpenter; Keith D. Lindor 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

To evaluate the efficacy of ursodeoxycholic acid as adjunctive therapy in type 1 autoimmune hepatitis, 37 patients who had experienced treatment failure, repeated relapse, or incomplete response were randomized to ursodeoxycholic acid (13-15 mg/kg daily) or placebo for 6 months in addition to their

Antiandrogenic treatment of benign prost

Antiandrogenic treatment of benign prostatic hyperplasia: a placebo controlled trial

✍ Ostri, P. ;Swartz, R. ;Meyhoff, H.-H. ;Petersen, J.H. ;Lindg�rd, G. ;Frimodt-M�l 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 401 KB

Thymosin treatment of chronic hepatitis

Thymosin treatment of chronic hepatitis B: A placebo-controlled pilot trial

✍ Milton G. Mutchnick; Henry D. Appelman; H. T. Chung; Emma Aragona; Tej P. Gupta; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 828 KB

Chronic hepatitis B is a severe and frequently progressive disease. We assessed the safety and efficacy of thymosin fraction 5 and thymosin-alpha 1 in a prospective, placebo-controlled trial in 12 patients with chronic hepatitis B. All patients had histological and biochemical evidence of active liv